1 508 131 COMPARATIVE EFFICACY OF A 12 WEEK YOGA-BASED LIFESTYLE INTERVENTION AND DIETARY INTERVENTION ON ADIPOKINES, INFLAMMATION, AND OXIDATIVE STRESS IN ADULTS WITH METABOLIC SYNDROME: A RANDOMIZED CONTROLLED TRIAL. THE PRESENT RANDOMIZED CONTROLLED TRIAL (RCT) EVALUATED THE COMPARATIVE EFFICACY OF 12 WEEK YOGA-BASED LIFESTYLE INTERVENTION (YBLI) AND DIETARY INTERVENTION (DI) ALONE ON ADIPOKINES, INFLAMMATION, AND OXIDATIVE STRESS IN INDIAN ADULTS WITH METABOLIC SYNDROME (MET S). A PARALLEL, TWO ARM, RCT WAS CONDUCTED IN INTEGRAL HEALTH CLINIC (IHC), ALL INDIA INSTITUTE OF MEDICAL SCIENCES, INDIA FROM 2012 TO 2014. IHC IS AN OUTPATIENT FACILITY CONDUCTING YBLI PROGRAMS FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. TWO HUNDRED SIXTY MEN AND WOMEN (20-45 YEARS) VISITING THE OUTPATIENT DEPARTMENT OF A TERTIARY CARE HOSPITAL WERE DIAGNOSED WITH MET S AND RANDOMIZED 1:1 TO RECEIVE 12 WEEK YBLI (N = 130) OR DI (N = 130). PRIMARY OUTCOMES WERE CHANGE IN PLASMA LEVELS OF ADIPOKINES (LEPTIN, ADIPONECTIN, AND LEPTIN:ADIPONECTIN RATIO), MARKERS OF INFLAMMATION (TUMOR NECROSIS FACTOR [TNF]-ALPHA, INTERLEUKIN [IL]-6), MARKERS OF OXIDATIVE STRESS (THIOBARBITURIC ACID REACTIVE SUBSTANCES [TBARS], 8-HYDROXY-2'-DEOXYGUANOSINE [8-OHDG], AND SUPEROXIDE DISMUTASE [SOD]) MEASURED AT BASELINE, 2 WEEKS, AND 12 WEEKS. YBLI GROUP SHOWED A SIGNIFICANT DECREASE IN LEPTIN, LEPTIN:ADIPONECTIN RATIO, IL-6, 8-OHDG, AND TBARS LEVELS, WHEREAS THERE WAS A SIGNIFICANT INCREASE IN ADIPONECTIN AND SOD LEVELS. NO SIGNIFICANT CHANGES WERE NOTICED IN DI ALONE GROUP. YBLI SHOWED SIGNIFICANTLY GREATER REDUCTION IN TBARS LEVELS THAN IN DI GROUP, SUGGESTIVE OF REDUCED OXIDATIVE STRESS IN ADULTS WITH MET S. A 12 WEEK YBLI HAD A POSITIVE IMPACT ON OXIDATIVE STRESS VERSUS DI ALONE IN ADULTS WITH MET S. 2019 2 1783 55 PREDICTORS OF HEALTH-RELATED QUALITY OF LIFE IN INDIANS WITH METABOLIC SYNDROME UNDERGOING RANDOMIZED CONTROLLED TRIAL OF YOGA-BASED LIFESTYLE INTERVENTION VS DIETARY INTERVENTION. THE PRESENT STUDY EXPLORES THE EFFICACY OF 12-WEEK YOGA + DIET-BASED LIFESTYLE INTERVENTION (YBLI) VS DIETARY INTERVENTION (DI) ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND IDENTIFIES THE PREDICTORS OF CHANGE IN HRQOL IN INDIANS WITH METABOLIC SYNDROME (MET S). DATA FROM THE HISTORICAL RANDOMIZED CONTROLLED TRIAL WAS USED INCLUDING ADULTS (N = 260, 20-45 YEARS) WITH MET S. FOUR DOMAINS OF HRQOL WERE MEASURED AT BASELINE, 2 AND 12 WEEKS USING WHOQOL-BREF QUESTIONNAIRE. GENERALIZED ESTIMATING EQUATION AND CHI-SQUARE TEST WAS USED TO COMPARE 12-WEEK CHANGES IN HRQOL DOMAINS AND PROPORTION OF SUBJECTS, RESPECTIVELY. CHANGES IN HRQOL WERE PREDICTED USING REGRESSION MODELS CONCERNING CHANGES IN BODY MASS INDEX (BMI), PHYSICAL ACTIVITY, TOTAL CALORIE INTAKE, ADIPONECTIN, AND SUPEROXIDE DISMUTASE (SOD) LEVELS. EXPLORATORY MEDIATION ANALYSIS WAS CARRIED OUT USING BARON & KENNY APPROACH. YBLI RESULTED IN A SIGNIFICANTLY GREATER INCREASE IN THE PHYSICAL DOMAIN SCORE OF HRQOL THAN DI. A SIGNIFICANTLY GREATER PROPORTION OF SUBJECTS IN YBLI GROUP (71%) SHOWED AN INCREASE IN PHYSICAL DOMAIN SCORES COMPARED TO DI (51%). A UNIT CHANGE IN BMI NEGATIVELY PREDICTED A UNIT CHANGE IN PHYSICAL, PSYCHOLOGICAL AND ENVIRONMENTAL HEALTH. WHEREAS, A UNIT CHANGE IN ADIPONECTIN AND SOD LEVELS POSITIVELY PREDICTED A UNIT CHANGE IN PHYSICAL AND ENVIRONMENTAL HEALTH. PARTIAL MEDIATION BETWEEN YBLI INTERVENTION AND PHYSICAL HRQOL DOMAIN WAS OBSERVED VIA ADIPONECTIN. IN CONCLUSION, A 12-WEEK YBLI HAS A POSITIVE AND GREATER EFFECT ON HRQOL PHYSICAL DOMAIN SCORE THAN FOLLOWING DI ALONE. CHANGES IN BMI, ADIPONECTIN, AND SOD LEVELS MAY PREDICT CHANGES IN HRQOL DOMAINS AFTER LIFESTYLE INTERVENTION. 2021 3 1860 49 RANDOMIZED CONTROLLED TRIAL OF A 12-WEEK YOGA-BASED (INCLUDING DIET) LIFESTYLE VS. DIETARY INTERVENTION ON CARDIO-METABOLIC RISK FACTORS AND CONTINUOUS RISK SCORE IN INDIAN ADULTS WITH METABOLIC SYNDROME. METABOLIC SYNDROME, A PREDIABETIC AND PRECARDIOVASCULAR PATHOLOGIC CONDITION THAT BEGINS EARLY IN LIFE, TRACKS INTO ADULTHOOD AND MAGNIFIES WITH AGE. RANDOMIZED CONTROLLED TRIALS EVALUATING EFFICACY OF YOGA-BASED LIFESTYLE VS. DIETARY INTERVENTION ON METABOLIC SYNDROME ARE LACKING. HERE, THE EFFICACY OF A 12-WEEK YOGA-BASED LIFESTYLE INTERVENTION VS. DIETARY INTERVENTION ON CARDIO-METABOLIC RISK FACTORS AND METABOLIC SYNDROME RISK SCORES HAVE BEEN ASSESSED IN INDIAN ADULTS WITH METABOLIC SYNDROME. IN THIS TWO-ARM, OPEN LABEL, PARALLEL GROUP, RANDOMIZED CONTROLLED TRIAL, 260 ADULTS (20-45 YEARS) DIAGNOSED WITH METABOLIC SYNDROME AS PER JOINT INTERIM STATEMENT, 2009 WERE RANDOMIZED TO YOGA-BASED (INCLUDING DIET) LIFESTYLE OR DIETARY INTERVENTION ALONE (N = 130, EACH) FOR 12 WEEKS. PRIMARY ENDPOINTS WERE THE 12-WEEK CHANGES IN CARDIO-METABOLIC RISK FACTORS AND METABOLIC RISK SCORES. THE SECONDARY ENDPOINTS WERE THE 12-WEEK CHANGES IN THE PROPORTION OF SUBJECTS RECOVERED FROM METABOLIC SYNDROME, DIETARY INTAKE, AND PHYSICAL ACTIVITY. INTENT-TO-TREAT ANALYSIS WAS PERFORMED INCLUDING ALL THE SUBJECTS WITH BASELINE DATA WITH IMPUTED MISSING DATA. TREATMENT X TIME INTERACTION SHOWED YOGA-BASED LIFESTYLE INTERVENTION HAD A GREATER TREATMENT EFFECT OVER DIETARY INTERVENTION BY SIGNIFICANTLY REDUCING WAIST CIRCUMFERENCE, CONTINUOUS METABOLIC SYNDROME Z-SCORE, AND DIETARY INTAKE/DAY WHILE SIGNIFICANTLY INCREASING PHYSICAL ACTIVITY. HIGH-DENSITY LIPOPROTEIN CHOLESTEROL SHOWED A SIGNIFICANTLY GREATER REDUCTION FOLLOWING DIETARY INTERVENTION THAN YOGA-BASED LIFESTYLE INTERVENTION. A SIGNIFICANTLY GREATER PROPORTION OF SUBJECTS RECOVERED FROM METABOLIC SYNDROME IN YOGA-BASED LIFESTYLE (45.4%) VS. DIETARY INTERVENTION GROUP (32.3%). A 12-WEEK YOGA-BASED LIFESTYLE INTERVENTION IS MORE EFFICACIOUS THAN USUAL DIETARY INTERVENTION IN IMPROVING CARDIO-METABOLIC RISK FACTOR AND METABOLIC RISK SCORE IN INDIAN ADULTS WITH METABOLIC SYNDROME. 2020 4 674 37 EFFECT OF A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION ON HEALTH-RELATED QUALITY OF LIFE IN OVERWEIGHT AND OBESE SUBJECTS. OBJECTIVE: TO STUDY THE EFFECT OF A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN OVERWEIGHT AND OBESE PERSONS. DESIGN AND SETTING: NONRANDOMIZED, SINGLE-ARM INTERVENTIONAL STUDY CONDUCTED FROM AUGUST 2012 TO MARCH 2015 AT INTEGRAL HEALTH CLINIC, DEPARTMENT OF PHYSIOLOGY, ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI, INDIA. PARTICIPANTS: OVERWEIGHT (BODY-MASS INDEX [BMI], 23-24.9 KG/M(2)) AND OBESE (BMI, >/=25 KG/M(2)) PERSONS (N = 279) AGED 20-60 YEARS. INTERVENTION: PRETESTED YOGA-BASED LIFESTYLE INTERVENTION, INCLUDING ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), RELAXATION TECHNIQUES, LECTURES, GROUP SUPPORT, NUTRITION AWARENESS PROGRAM, AND INDIVIDUALIZED ADVICE. OUTCOME MEASURES: PRIMARY OUTCOME MEASURE WAS HRQOL, MEASURED BY USING SHORT VERSION OF WORLD HEALTH ORGANIZATION QUALITY OF LIFE (WHOQOL-BREF) QUESTIONNAIRE. SECONDARY OUTCOME MEASURES WERE ANTHROPOMETRIC VARIABLES, SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, PULSE RATE, LIPID PROFILE, AND FASTING GLUCOSE. A SUBGROUP ANALYSIS ACCORDING TO SEX WAS ALSO PERFORMED. RESULTS: THE OVERALL QUALITY OF LIFE AND HEALTH IMPROVED AFTER SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OVERWEIGHT AND OBESE PERSONS. PHYSICAL, PSYCHOLOGICAL AND ENVIRONMENTAL DOMAIN SCORES SIGNIFICANTLY INCREASED FROM BASELINE TO DAY 10, AND EFFICACY WAS NOTED IN BOTH MALE AND FEMALE SUBGROUPS. AFTER 10 DAYS OF INTERVENTION, THE FOLLOWING ALSO DECREASED SIGNIFICANTLY: BODY WEIGHT, BMI, TOTAL BODY FAT, WAIST AND HIP CIRCUMFERENCE, WAIST-TO-HIP RATIO, SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, TOTAL CHOLESTEROL, LOW-DENSITY LIPOPROTEIN, TRIGLYCERIDES, AND FASTING GLUCOSE. CONCLUSION: A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION HAD A POSITIVE EFFECT ON HRQOL IN OVERWEIGHT AND OBESE PERSONS. 2016 5 39 40 A BRIEF BUT COMPREHENSIVE LIFESTYLE EDUCATION PROGRAM BASED ON YOGA REDUCES RISK FACTORS FOR CARDIOVASCULAR DISEASE AND DIABETES MELLITUS. OBJECTIVES: THE OBJECTIVE OF THE STUDY WAS TO STUDY THE SHORT-TERM IMPACT OF A BRIEF LIFESTYLE INTERVENTION BASED ON YOGA ON SOME OF THE BIOCHEMICAL INDICATORS OF RISK FOR CARDIOVASCULAR DISEASE AND DIABETES MELLITUS. DESIGN: THE VARIABLES OF INTEREST WERE MEASURED AT THE BEGINNING (DAY 1) AND END (DAY 10) OF THE INTERVENTION USING A PRE-POST DESIGN. SETTING: THE STUDY IS THE RESULT OF OPERATIONAL RESEARCH CARRIED OUT IN OUR INTEGRAL HEALTH CLINIC (IHC). THE IHC IS AN OUTPATIENT FACILITY WHICH CONDUCTS 8-DAY LIFESTYLE MODIFICATION PROGRAMS BASED ON YOGA FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASE. A NEW COURSE BEGINS EVERY ALTERNATE WEEK OF THE YEAR. SUBJECTS: THE STUDY IS BASED ON DATA COLLECTED ON 98 SUBJECTS (67 MALE, 31 FEMALE), AGES 20-74 YEARS, WHO ATTENDED ONE OF OUR PROGRAMS. THE SUBJECTS WERE A HETEROGENEOUS GROUP OF PATIENTS WITH HYPERTENSION, CORONARY ARTERY DISEASE, DIABETES MELLITUS, AND A VARIETY OF OTHER ILLNESSES. INTERVENTION: THE INTERVENTION CONSISTED OF ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), RELAXATION TECHNIQUES, GROUP SUPPORT, INDIVIDUALIZED ADVICE, LECTURES AND FILMS ON THE PHILOSOPHY OF YOGA AND THE PLACE OF YOGA IN DAILY LIFE, MEDITATION, STRESS MANAGEMENT, NUTRITION, AND KNOWLEDGE ABOUT THE ILLNESS. OUTCOME MEASURES: THE OUTCOME MEASURES WERE FASTING PLASMA GLUCOSE AND SERUM LIPOPROTEIN PROFILE. THESE VARIABLES WERE DETERMINED IN FASTING BLOOD SAMPLES, TAKEN ON THE FIRST AND LAST DAY OF THE COURSE. RESULTS: FASTING PLASMA GLUCOSE, SERUM TOTAL CHOLESTEROL, LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL, VERY- LDL CHOLESTEROL, THE RATIO OF TOTAL CHOLESTEROL TO HIGH DENSITY LIPOPROTEIN (HDL) CHOLESTEROL, AND TOTAL TRIGLYCERIDES WERE SIGNIFICANTLY LOWER, AND HDL CHOLESTEROL SIGNIFICANTLY HIGHER, ON THE LAST DAY OF THE COURSE COMPARED TO THE FIRST DAY OF THE COURSE. THE CHANGES WERE MORE MARKED IN SUBJECTS WITH HYPERGLYCEMIA OR HYPERCHOLESTEROLEMIA. CONCLUSIONS: THE OBSERVATIONS SUGGEST THAT A SHORT LIFESTYLE MODIFICATION AND STRESS MANAGEMENT EDUCATION PROGRAM LEADS TO FAVORABLE METABOLIC EFFECTS WITHIN A PERIOD OF 9 DAYS. 2005 6 2834 37 YOGA'S EFFECT ON INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS IN A HIGH RISK POPULATION - A CONTROLLED TRIAL IN PRIMARY CARE. BACKGROUND: YOGA CAN REDUCE BLOOD PRESSURE AND HAS ALSO BEEN SUGGESTED TO REDUCE INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS FOR CARDIOVASCULAR DISEASES (CVDS). WE AIMED TO ASSESS THE BENEFIT OF TWO YOGA INTERVENTIONS ON INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS IN A HIGH RISK POPULATION IN PRIMARY CARE. METHODS: ADULT PATIENTS FROM A HEALTH CARE CENTER IN SWEDEN, WITH DIAGNOSED HYPERTENSION, WERE INVITED TO UNDERGO A BASELINE CHECK AT THE HEALTH CARE CENTER. BASELINE CHECK INCLUDED STANDARDIZED BLOOD PRESSURE MEASUREMENT, BMI AND WEIGHT CIRCUMFERENCE MEASUREMENTS, BLOOD SAMPLING (HS-CRP, IL-6, FP-GLUCOSE, HBA1C, CHOLESTEROL, TG, LDL AND HDL) AND A QUESTIONNAIRE ON SELF-RATED QUALITY OF LIFE (WHOQOL-BREF). THERE WERE THREE GROUPS: 1) YOGA CLASS WITH YOGA INSTRUCTOR; 2) YOGA AT HOME; AND 3) A CONTROL GROUP. IN TOTAL, 83 PATIENTS WERE INCLUDED AND MATCHED AT THE GROUP LEVEL FOR SYSTOLIC BLOOD PRESSURE. A MAJORITY OF THE PATIENTS (92 %) WERE ON ANTIHYPERTENSIVE MEDICATION, WHICH THEY WERE REQUESTED NOT TO CHANGE DURING THE STUDY. AFTER 12 WEEKS OF INTERVENTION, THE ASSESSMENTS WERE PERFORMED AGAIN. RESULTS: WE RECORDED NO EVIDENCE THAT YOGA ALTERED INFLAMMATORY BIOMARKERS OR METABOLIC RISK FACTORS IN OUR STUDY POPULATION. A TOTAL OF 49 PARTICIPANTS (59 %) MET THE CRITERIA FOR METABOLIC SYNDROME. CONCLUSION: THE YOGA INTERVENTIONS PERFORMED IN OUR STUDY DID NOT AFFECT INFLAMMATORY BIOMARKERS OR METABOLIC RISK FACTORS ASSOCIATED WITH CVD IN THE STUDY POPULATION OF PRIMARY CARE PATIENTS WITH HYPERTENSION. FURTHER RANDOMIZED TRIALS ARE NEEDED TO ELUCIDATE THE EFFECTS OF YOGA ON CVD RISK FACTORS IN THIS PARTICULAR GROUP. TRAIL REGISTRATION: NCT01302535 , FEBRUARY 22, 2011. 2015 7 35 57 A 12-WEEK YOGA-BASED LIFESTYLE INTERVENTION MIGHT POSITIVELY MODIFY CELLULAR AGING IN INDIAN OBESE INDIVIDUALS: A RANDOMIZED-CONTROLLED TRIAL. BACKGROUND: TELOMERES AND TELOMERASE ARE CONSIDERED CARDINAL BIOMARKERS OF CELLULAR AGING. SHORTER TELOMERES AND LOW TELOMERASE ACTIVITY HAVE BEEN ASSOCIATED WITH OBESITY AND ACCELERATED AGING. OBJECTIVE: TO COMPARE THE EFFECTS OF A YOGA-BASED LIFESTYLE INTERVENTION (YBLI) WITH THE STANDARD OF CARE (SOC) ON CELLULAR AGING BY ESTIMATING TELOMERE LENGTH (TL) AND TELOMERASE ACTIVITY IN OBESITY. DESIGN AND SETTING: A PARALLEL, TWO-ARM, RANDOMIZED-CONTROLLED TRIAL WAS CONDUCTED AT THE INTEGRAL HEALTH CLINIC, DEPARTMENT OF PHYSIOLOGY, ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI, FROM MARCH 2017 TO OCTOBER 2019. PARTICIPANTS: OBESE (N = 72), BODY MASS INDEX (BMI), 25-35 KG/M(2), AGED 20-45 YEARS, MALE (21), AND FEMALE (51). INTERVENTION: SEVENTY-TWO OBESE PARTICIPANTS WERE RANDOMIZED TO RECEIVE EITHER A 12-WEEK SOC (N = 36) OR YBLI (N = 36). SOC INCLUDED MANAGEMENT OF OBESITY AS PER INDIAN GUIDELINES INCLUDING A HYPOCALORIC INDIVIDUALIZED DIET AND PHYSICAL ACTIVITY. THE PRETESTED YBLI INCLUDED ASANA (PHYSICAL POSTURES), PRANAYAMA (BREATHING EXERCISES), AND MEDITATION. METHODS: BLOOD SAMPLES WERE COLLECTED FROM BOTH THE GROUPS AT BASELINE, 2, 4, AND 12 WEEKS. DNA WAS EXTRACTED FROM PERIPHERAL BLOOD MONONUCLEAR CELLS. TL WAS MEASURED BY QUANTITATIVE PCR, AND SERUM TELOMERASE LEVELS BY IMMUNOASSAY. OUTCOME MEASURES: PRIMARY OUTCOME MEASURES WERE THE CHANGES IN THE TL AND TELOMERASE LEVELS BETWEEN THE TWO GROUPS AT WEEK 12. SECONDARY OUTCOME MEASURES WERE THE CHANGES IN TL AND TELOMERASE, AND ANTHROPOMETRIC PARAMETERS (BODY WEIGHT, BMI, WAIST-TO-HIP RATIO) AT 2, 4, AND 12 WEEKS OF INTERVENTION IN BOTH SOC AND YBLI GROUPS. RESULTS: THERE WERE NO SIGNIFICANT CHANGES IN TL AND TELOMERASE LEVELS BETWEEN THE GROUPS AT WEEK 12. THE TL WAS SIGNIFICANTLY GREATER IN THE YBLI GROUP VERSUS THE SOC GROUP (P < 0.0001) AT 2 WEEKS. THE ANTHROPOMETRIC AND PHYSIOLOGICAL PARAMETERS WERE INFLUENCED POSITIVELY BY BOTH SOC AND YBLI. CONCLUSION: THE STUDY DID NOT MEET THE PRIMARY OBJECTIVE, ALTHOUGH THE RESULTS ARE SUGGESTIVE OF A POSITIVE IMPACT OF YBLI ON AGING IN OBESITY AS NOTED WITHIN THE YBLI GROUP. HOWEVER, THE RESULTS SHOULD BE INTERPRETED CAREFULLY, AND IN THE LIGHT OF OTHER PUBLISHED DATA. LARGER STUDIES TO BETTER UNDERSTAND THE POSSIBLE POSITIVE BENEFITS OF YBLI ON CELLULAR AGING ARE RECOMMENDED. CLINICAL TRAIL REGISTRATION NO. CTRI/2016/08/007136. 2022 8 1104 28 EFFECTS OF YOGA VERSUS SHAM YOGA ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS: A SINGLE-BLINDED RANDOMIZED PILOT STUDY. STUDIES HAVE SHOWN A BENEFICIAL ROLE OF YOGA IN TRE A T I N G TYPE 2 DIABETES MELLITUS. THE PRESENT STUDY PROCEEDS IN THE FIELD BY PROVIDING AN ACTIVE CONTROL. WE AIMED TO EVALUATE THE EFFECT OF 3 MONTHS OF YOGA ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS. FORTY PARTICIPANTS WERE RANDOMIZED TO RECEIVE EITHER YOGA (N = 20) OR SHAM YOGA (N = 20) AS A CONTROL. YOGA INCLUDED POSTURES AND BREATHING EXERCISES, AND NONAEROBIC STRETCHING EXERCISE COMPRISED THE CONTROL. SIGNIFICANT WITHIN-GROUP DIFFERENCES IN MALONDIALDEHYDE, VITAMIN C, SUPEROXIDE DISMUTASE, FASTING BLOOD GLUCOSE, GLYCOSYLATED HEMOGLOBIN, BODY MASS INDEX, WAIST CIRCUMFERENCE, AND BLOOD PRESSURE WERE EVIDENT IN BOTH GROUPS. YOGA PARTICIPANTS HAD SIGNIFICANTLY GREATER IMPROVEMENT IN REDUCED GLUTATHIONE COMPARED TO CONTROLS. NO SIGNIFICANT DIFFERENCES BETWEEN GROUPS WERE OBSERVED IN ANY OTHER OUTCOME VARIABLES. YOGA AND SHAM YOGA HAD IDENTICAL EFFECTS ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS. LEVELS OF REDUCED GLUTATHIONE IMPROVED ONLY IN THE YOGA GROUP. THIS RESEARCH NEEDS TO BE CONFIRMED BY LARGER AND SUFFICIENTLY POWERED STUDIES. 2020 9 2038 49 TELOMERASE ACTIVITY AND CELLULAR AGING MIGHT BE POSITIVELY MODIFIED BY A YOGA-BASED LIFESTYLE INTERVENTION. OBJECTIVES: RECENT STUDIES SHOWED THAT A BRIEF YOGA-BASED LIFESTYLE INTERVENTION WAS EFFICACIOUS IN REDUCING LEVELS OF OXIDATIVE STRESS AND CELLULAR AGING IN OBESE MEN. THE OBJECTIVE OF THIS CASE REPORT WAS TO ASSESS THE EFFICACY OF THIS INTERVENTION IN REDUCING THE LEVELS OF BIOCHEMICAL MARKERS OF CELLULAR AGEING, OXIDATIVE STRESS, AND INFLAMMATION AT BASELINE (DAY 0), AT THE END OF ACTIVE INTERVENTION (DAY 10), AND FOLLOW-UP AT DAY 90. DESIGN: SINGLE CASE REPORT FROM A PROSPECTIVE ONGOING STUDY WITH PRE-POST DESIGN ASSESSING THE LEVEL OF VARIOUS MARKERS OF CELLULAR AGING. SETTING: INTEGRAL HEALTH CLINIC, AN OUTPATIENT FACILITY CONDUCTING MEDITATION AND YOGA-BASED LIFESTYLE INTERVENTION PROGRAMS FOR MANAGEMENT OF CHRONIC DISEASES. PATIENT: A 31-YEAR-OLD MAN WITH CLASS I OBESITY (BODY-MASS INDEX, 29.5 KG/M(2)) WHO PRESENTED TO THE MEDICINE OUTPATIENT DEPARTMENT AT ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI, INDIA, WITH A HISTORY OF FATIGUE, DIFFICULTY LOSING WEIGHT, AND LACK OF MOTIVATION. HE NOTED A MARKED DECREASE IN HIS ENERGY LEVEL, PARTICULARLY IN THE AFTERNOON. INTERVENTION: A PRETESTED INTERVENTION PROGRAM INCLUDED ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), STRESS MANAGEMENT, GROUP DISCUSSIONS, LECTURES, AND INDIVIDUALIZED ADVICE. RESULTS: FROM BASELINE (DAY 0) TO DAY 90, THE ACTIVITY OF TELOMERASE AND LEVELS OF BETA-ENDORPHINS, PLASMA CORTISOL, AND INTERLEUKIN-6 INCREASED, AND A SUSTAINED REDUCTION IN OXIDATIVE STRESS MARKERS, SUCH AS REACTIVE OXYGEN SPECIES AND 8-HYDROXY-2-DEOXY-GUANOSINE LEVELS. CONCLUSIONS: ADOPTING YOGA/MEDITATION-BASED LIFESTYLE MODIFICATION CAUSES REVERSAL OF MARKERS OF AGING, MAINLY OXIDATIVE STRESS, TELOMERASE ACTIVITY, AND OXIDATIVE DNA DAMAGE. THIS MAY NOT ONLY DELAY AGING AND PROLONG A YOUTHFUL HEALTHY LIFE BUT ALSO DELAY OR PREVENT ONSET OF SEVERAL LIFESTYLE-RELATED DISEASES, OF WHICH OXIDATIVE STRESS AND INFLAMMATION ARE THE CHIEF CAUSE. THIS REPORT SUGGESTS THIS SIMPLE LIFESTYLE INTERVENTION MAY BE THERAPEUTIC FOR OXIDATIVE DNA DAMAGE AND OXIDATIVE STRESS. 2015 10 881 38 EFFECT OF YOGA TRAINING ON INFLAMMATORY CYTOKINES AND C-REACTIVE PROTEIN IN EMPLOYEES OF SMALL-SCALE INDUSTRIES. OBJECTIVE: THE PRESENT STUDY INTENDS TO SEE THE EFFECT OF YOGA PRACTICES ON LIPID PROFILE, INTERLEUKIN (IL)-6, TUMOR NECROSIS FACTOR (TNF)-ALPHA, AND HIGH-SENSITIVITY-C-REACTIVE PROTEIN (HS-CRP) AMONG APPARENTLY HEALTHY ADULTS EXPOSED TO OCCUPATIONAL HAZARDS. MATERIALS AND METHODS: IN THE PRESENT STUDY, 48 PARTICIPANTS AGED 30-58 YEARS (41.5 +/- 5.2) WHO WERE EXPOSED TO OCCUPATIONAL HAZARDS WERE RANDOMIZED INTO TWO GROUPS, THAT IS, EXPERIMENTAL AND WAIT-LIST CONTROL. ALL THE PARTICIPANTS WERE ASSESSED FOR LIPID PROFILE, IL-6, TNF-ALPHA, AND HS-CRP AT THE BASELINE AND AFTER COMPLETION OF 3 MONTHS OF YOGA TRAINING INTERVENTION. THE EXPERIMENTAL GROUP UNDERWENT YOGA TRAINING INTERVENTION FOR 1 H FOR 6 DAYS A WEEK FOR 3 MONTHS, WHEREAS CONTROL GROUP CONTINUED WITH THEIR DAILY ACTIVITIES EXCEPT YOGA TRAINING. DATA ANALYSIS WAS DONE USING STATISTICAL SOFTWARE SPSS VERSION 20.0. DATA WERE ANALYZED USING PAIRED T-TESTS AND INDEPENDENT T-TEST. RESULTS: THE RESULTS OF WITHIN GROUP COMPARISON REVEALED HIGHLY SIGNIFICANT CHANGES IN CHOLESTEROL (P < 0.001), HIGH-DENSITY LIPOPROTEIN (P < 0.001), LOW-DENSITY LIPOPROTEIN (LDL)(P < 0.01), HS-CRP (P < 0.01), IL-6 (P < 0.001), AND TNF-ALPHA (P < 0.001) IN EXPERIMENTAL GROUP. COMPARISON BETWEEN EXPERIMENTAL AND CONTROL GROUP REVEALED SIGNIFICANT CHANGES IN CHOLESTEROL (P < 0.01), LDL (P < 0.05), IL-6 (P < 0.01), TNF-ALPHA (P < 0.01), AND HS-CRP (P < 0.01). CONCLUSION: A YOGA-BASED LIFESTYLE INTERVENTION SEEMS TO BE A HIGHLY PROMISING ALTERNATIVE THERAPY WHICH FAVORABLY ALTERS INFLAMMATORY MARKERS AND METABOLIC RISK FACTORS. 2017 11 662 30 EFFECT OF 3-MONTH YOGA ON OXIDATIVE STRESS IN TYPE 2 DIABETES WITH OR WITHOUT COMPLICATIONS: A CONTROLLED CLINICAL TRIAL. OBJECTIVE: TO ASSESS THE EFFECT OF YOGA ON ANTHROPOMETRY, BLOOD PRESSURE, GLYCEMIC CONTROL, AND OXIDATIVE STRESS IN TYPE 2 DIABETIC PATIENTS ON STANDARD CARE IN COMPARISON WITH STANDARD CARE ALONE. RESEARCH DESIGN AND METHODS: THE STUDY INVOLVED 123 PATIENTS STRATIFIED ACCORDING TO GROUPS WITH MICROVASCULAR COMPLICATIONS, MACROVASCULAR COMPLICATIONS, AND PERIPHERAL NEUROPATHY AND WITHOUT COMPLICATIONS AND ASSIGNED TO RECEIVE EITHER STANDARD CARE OR STANDARD CARE ALONG WITH ADDITIONAL YOGA FOR 3 MONTHS. RESULTS: IN COMPARISON WITH STANDARD CARE ALONE, YOGA RESULTED IN SIGNIFICANT REDUCTION IN BMI, GLYCEMIC CONTROL, AND MALONDIALDEHYDE AND INCREASE IN GLUTATHIONE AND VITAMIN C. THERE WERE NO DIFFERENCES IN WAIST CIRCUMFERENCE, WAIST-TO-HIP RATIO, BLOOD PRESSURE, VITAMIN E, OR SUPEROXIDE DISMUTASE IN THE YOGA GROUP AT FOLLOW-UP. CONCLUSIONS: YOGA CAN BE USED AS AN EFFECTIVE THERAPY IN REDUCING OXIDATIVE STRESS IN TYPE 2 DIABETES. YOGA IN ADDITION TO STANDARD CARE HELPS REDUCE BMI AND IMPROVE GLYCEMIC CONTROL IN TYPE 2 DIABETIC PATIENTS. 2011 12 1115 51 EFFICACY OF A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN REDUCING STRESS AND INFLAMMATION: PRELIMINARY RESULTS. OBJECTIVES: PREVIOUSLY IT WAS SHOWN THAT A BRIEF YOGA-BASED LIFESTYLE INTERVENTION WAS EFFICACIOUS IN REDUCING OXIDATIVE STRESS AND RISK OF CHRONIC DISEASES EVEN IN A SHORT DURATION. THE OBJECTIVE OF THIS STUDY WAS TO ASSESS THE EFFICACY OF THIS INTERVENTION IN REDUCING STRESS AND INFLAMMATION IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES. DESIGN: THIS STUDY REPORTS PRELIMINARY RESULTS FROM A NONRANDOMIZED PROSPECTIVE ONGOING STUDY WITH PRE-POST DESIGN. SETTING/LOCATION: THE STUDY WAS CONDUCTED AT THE INTEGRAL HEALTH CLINIC, AN OUTPATIENT FACILITY CONDUCTING THESE YOGA-BASED LIFESTYLE INTERVENTION PROGRAMS FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. SUBJECTS: PATIENTS WITH CHRONIC INFLAMMATORY DISEASES AND OVERWEIGHT/OBESE SUBJECTS WERE INCLUDED WHILE PHYSICALLY CHALLENGED, AND THOSE ON OTHER INTERVENTIONS WERE EXCLUDED FROM THE STUDY. INTERVENTION: A PRETESTED INTERVENTION PROGRAM INCLUDED ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), STRESS MANAGEMENT, GROUP DISCUSSIONS, LECTURES, AND INDIVIDUALIZED ADVICE. OUTCOME MEASURES: THERE WAS A REDUCTION IN STRESS (PLASMA CORTISOL AND BETA-ENDORPHIN) AND INFLAMMATION (INTERLEUKIN [IL]-6 AND TUMOR NECROSIS FACTOR [TNF]-ALPHA) AT DAY 0 VERSUS DAY 10. RESULTS: EIGHTY-SIX (86) PATIENTS (44 FEMALE, 42 MALE, 40.07 +/- 13.91 YEARS) ATTENDED THIS PROGRAM. OVERALL, THE MEAN LEVEL OF CORTISOL DECREASED FROM BASELINE TO DAY 10 (149.95 +/- 46.07, 129.07 +/- 33.30 NG/ML; P=0.001) WHILE BETA-ENDORPHINS INCREASED FROM BASELINE TO DAY 10 (3.53 +/- 0.88, 4.06 +/- 0.79 NG/ML; P=0.024). ALSO, THERE WAS REDUCTION FROM BASELINE TO DAY 10 IN MEAN LEVELS OF IL-6 (2.16 +/- 0.42, 1.94 +/- 0.10 PG/ML, P=0.036) AND TNF-ALPHA (2.85 +/- 0.59, 1.95 +/- 0.32 PG/ML, P=0.002). CONCLUSIONS: THIS BRIEF YOGA-BASED LIFESTYLE INTERVENTION REDUCED THE MARKERS OF STRESS AND INFLAMMATION AS EARLY AS 10 DAYS IN PATIENTS WITH CHRONIC DISEASES; HOWEVER, COMPLETE RESULTS OF THIS STUDY WILL CONFIRM WHETHER THIS PROGRAM HAS UTILITY AS COMPLEMENTARY AND ALTERNATIVE THERAPY. 2012 13 247 46 A YOGA INTERVENTION FOR TYPE 2 DIABETES RISK REDUCTION: A PILOT RANDOMIZED CONTROLLED TRIAL. BACKGROUND: TYPE 2 DIABETES IS A MAJOR HEALTH PROBLEM IN MANY COUNTRIES INCLUDING INDIA. YOGA MAY BE AN EFFECTIVE TYPE 2 DIABETES PREVENTION STRATEGY IN INDIA, PARTICULARLY GIVEN ITS CULTURAL FAMILIARITY. METHODS: THIS WAS A PARALLEL, RANDOMIZED CONTROLLED PILOT STUDY TO COLLECT FEASIBILITY AND PRELIMINARY EFFICACY DATA ON YOGA FOR DIABETES RISK FACTORS AMONG PEOPLE AT HIGH RISK OF DIABETES. PRIMARY OUTCOMES INCLUDED: CHANGES IN BMI, WAIST CIRCUMFERENCE, FASTING BLOOD GLUCOSE, POSTPRANDIAL BLOOD GLUCOSE, INSULIN, INSULIN RESISTANCE, BLOOD PRESSURE, AND CHOLESTEROL. WE ALSO LOOKED AT MEASURES OF PSYCHOLOGICAL WELL-BEING INCLUDING CHANGES IN DEPRESSION, ANXIETY, POSITIVE AND NEGATIVE AFFECT AND PERCEIVED STRESS. FORTY-ONE PARTICIPANTS WITH ELEVATED FASTING BLOOD GLUCOSE IN BANGALORE, INDIA WERE RANDOMIZED TO EITHER YOGA (N = 21) OR A WALKING CONTROL (N = 20). PARTICIPANTS WERE ASKED TO EITHER ATTEND YOGA CLASSES OR COMPLETE MONITORED WALKING 3-6 DAYS PER WEEK FOR EIGHT WEEKS. RANDOMIZATION AND ALLOCATION WAS PERFORMED USING COMPUTER-GENERATED RANDOM NUMBERS AND GROUP ASSIGNMENTS DELIVERED IN SEALED, OPAQUE ENVELOPES GENERATED BY OFF-SITE STUDY STAFF. DATA WERE ANALYZED BASED ON INTENTION TO TREAT. RESULTS: THIS STUDY WAS FEASIBLE IN TERMS OF RECRUITMENT, RETENTION AND ADHERENCE. IN ADDITION, YOGA PARTICIPANTS HAD SIGNIFICANTLY GREATER REDUCTIONS IN WEIGHT, WAIST CIRCUMFERENCE AND BMI VERSUS CONTROL (WEIGHT -0.8 +/- 2.1 VS. 1.4 +/- 3.6, P = 0.02; WAIST CIRCUMFERENCE -4.2 +/- 4.8 VS. 0.7 +/- 4.2, P < 0.01; BMI -0.2 +/- 0.8 VS. 0.6 +/- 1.6, P = 0.05). THERE WERE NO BETWEEN GROUP DIFFERENCES IN FASTING BLOOD GLUCOSE, POSTPRANDIAL BLOOD GLUCOSE, INSULIN RESISTANCE OR ANY OTHER FACTORS RELATED TO DIABETES RISK OR PSYCHOLOGICAL WELL-BEING. THERE WERE SIGNIFICANT REDUCTIONS IN SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, TOTAL CHOLESTEROL, ANXIETY, DEPRESSION, NEGATIVE AFFECT AND PERCEIVED STRESS IN BOTH THE YOGA INTERVENTION AND WALKING CONTROL OVER THE COURSE OF THE STUDY. CONCLUSION: AMONG INDIANS WITH ELEVATED FASTING BLOOD GLUCOSE, WE FOUND THAT PARTICIPATION IN AN 8-WEEK YOGA INTERVENTION WAS FEASIBLE AND RESULTED IN GREATER WEIGHT LOSS AND REDUCTION IN WAIST CIRCUMFERENCE WHEN COMPARED TO A WALKING CONTROL. YOGA OFFERS A PROMISING LIFESTYLE INTERVENTION FOR DECREASING WEIGHT-RELATED TYPE 2 DIABETES RISK FACTORS AND POTENTIALLY INCREASING PSYCHOLOGICAL WELL-BEING. TRIAL REGISTRATION: CLINICALTRIALS.GOV IDENTIFIED NCT00090506. 2014 14 692 32 EFFECT OF COMMUNITY-BASED YOGA INTERVENTION ON OXIDATIVE STRESS AND GLYCEMIC PARAMETERS IN PREDIABETES: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: TO STUDY THE EFFECTIVENESS OF YOGA INTERVENTION ON OXIDATIVE STRESS, GLYCEMIC STATUS, BLOOD PRESSURE AND ANTHROPOMETRY IN PREDIABETES. DESIGN: RANDOMIZED-CONTROLLED TRIAL. PARTICIPANTS: TWENTY NINE PREDIABETES SUBJECTS AGED 30-75 YEARS. SETTING: YOGA WAS CONDUCTED AT 4 DIFFERENT COMMUNITY DIABETES CLINICS IN MANGALORE, INDIA. INTERVENTIONS: PARTICIPANTS WERE RANDOMIZED TO EITHER 3-MONTH YOGA OR WAIT-LIST CONTROL GROUPS. MAIN OUTCOME MEASURES: MALONDIALDEHYDE, GLUTATHIONE, VITAMIN C, VITAMIN E, SUPEROXIDE DISMUTASE, PLASMA GLUCOSE, GLYCATED HAEMOGLOBIN, BMI, WAIST CIRCUMFERENCE, WAIST-TO-HIP RATIO AND BLOOD PRESSURE. RESULTS: YOGA INTERVENTION RESULTED IN A SIGNIFICANT DECLINE IN MALONDIALDEHYDE (P<0.001), RELATIVE TO THE CONTROL GROUP. IN COMPARISON WITH THE CONTROL, THERE WAS A SIGNIFICANT IMPROVEMENT IN BMI, WAIST CIRCUMFERENCE, SYSTOLIC BLOOD PRESSURE AND FASTING GLUCOSE LEVELS AT FOLLOW-UP. NO SIGNIFICANT IMPROVEMENT IN GLYCATED HAEMOGLOBIN, WAIST-TO-HIP RATIO OR ANY OF THE ANTIOXIDANTS WAS OBSERVED. CONCLUSIONS: YOGA INTERVENTION MAY BE HELPFUL IN CONTROL OF OXIDATIVE STRESS IN PREDIABETES SUBJECTS. YOGA CAN ALSO BE BENEFICIAL IN REDUCTION IN BMI, WAIST CIRCUMFERENCE, SYSTOLIC BLOOD PRESSURE AND FASTING GLUCOSE. EFFECT OF YOGA ON ANTIOXIDANT PARAMETERS WAS NOT EVIDENT IN THIS STUDY. THE FINDINGS OF THIS STUDY NEED TO BE CONFIRMED IN LARGER TRIALS INVOLVING ACTIVE CONTROL GROUPS. 2013 15 1102 38 EFFECTS OF YOGA TRAINING ON BODY COMPOSITION AND OXIDANT-ANTIOXIDANT STATUS AMONG HEALTHY MALE. BACKGROUND: THE STRESSFUL CONDITION MAY CAUSE OXIDATIVE STRESS, WHICH IS RESPONSIBLE FOR VARIOUS DISEASES. AIMS: THE PRESENT STUDY WAS DESIGNED TO FIND OUT WHETHER YOGA HAS IMPACT ON THE REDUCTION OF OXIDATIVE STRESS. METHODS: FOR THE PRESENT STUDY, 95 (N = 95) HEALTHY MALE VOLUNTEERS WITHIN THE AGE GROUP OF 18-24 YEARS WERE INCLUDED, 35 (N = 35) VOLUNTEERS WERE EXCLUDED. THE REMAINING 60 (N = 60) VOLUNTEERS WERE RANDOMLY DIVIDED INTO TWO GROUPS: (A) YOGA GROUP (N = 30) AND (B) CONTROL GROUP (N = 30). YOGA TRAINING WAS GIVEN FOR 60 MIN PER DAY, 6 DAYS PER WEEK FOR 12 WEEKS IN THE YOGA GROUP, WITH NO YOGA TRAINING IN CONTROL GROUP. ASSESSMENT OF BODY COMPOSITION AND OXIDANT-ANTIOXIDANT STATUS WERE PERFORMED IN BOTH THE GROUPS AT BASELINE, BEFORE YOGA TRAINING (0 WEEK) AND AFTER (12 WEEKS) OF THE TRAINING. RESULTS: SIGNIFICANT REDUCTION (P < 0.001) IN THE PERCENTAGE OF BODY FAT AND MALONDIALDEHYDE; SIGNIFICANT ELEVATION (P < 0.001) IN SUPEROXIDE DISMUTASE, CATALASE, REDUCED GLUTATHIONE AND ASCORBIC ACID LEVELS WERE NOTED IN THE YOGA GROUP AFTER 12 WEEKS WHEN COMPARED TO BASELINE DATA (0 WEEK). HOWEVER, THERE WAS NO SIGNIFICANT DIFFERENCE IN HEIGHT, WEIGHT, BODY MASS INDEX, BODY SURFACE AREA AND LEAN BODY MASS AMONG THE YOGA GROUP AFTER 12 WEEKS WHEN COMPARED TO BASELINE DATA. THESE CHANGES MIGHT BE DUE TO YOGA TRAINING. CONCLUSIONS: REGULAR YOGA PRACTICE REDUCES BODY FAT AND OXIDATIVE STRESS. YOGA TRAINING MAY BE HELPFUL TO REDUCE THE CHANCE OF OCCURRENCE OF VARIOUS DISEASES AND HELPS TO MAINTAIN NORMAL HEALTHY LIFESTYLE. 2018 16 986 24 EFFECTS OF HATHA YOGA EXERCISE ON PLASMA MALONDIALDEHYDE CONCENTRATION AND SUPEROXIDE DISMUTASE ACTIVITY IN FEMALE PATIENTS WITH SHOULDER PAIN. [PURPOSE] THE PURPOSE OF THIS STUDY WAS TO ANALYZE THE EFFECTS OF HATHA YOGA EXERCISE ON PLASMA MALONDIALDEHYDE (MDA) CONCENTRATION AND SUPEROXIDE DISMUTASE (SOD) ACTIVITY IN FEMALE PATIENTS WITH SHOULDER PAIN. [SUBJECTS] SUBJECTS COMPRISED 20 FEMALE PATIENTS WITH SHOULDER PAIN. [METHODS] SUBJECTS WERE DIVIDED INTO 2 GROUPS: A HATHA YOGA EXERCISE GROUP (N = 10) AND A CONTROL GROUP THAT PERFORMED NO EXERCISE (N = 10). THE SUBJECTS' BODY COMPOSITION, PLASMA MALONDIALDEHYDE CONCENTRATIONS, AND SUPEROXIDE DISMUTASE ACTIVITIES WERE MEASURED BEFORE AND AFTER A 16-WEEK HATHA YOGA EXERCISE PROGRAM. [RESULTS] AFTER THE 16-WEEK HATHA YOGA EXERCISE PROGRAM, THE EXERCISE GROUP HAD SIGNIFICANTLY LOWER PLASMA MDA CONCENTRATIONS THAN THE CONTROL GROUP. IN ADDITION, THE EXERCISE GROUP HAD SIGNIFICANTLY HIGHER PLASMA SOD ACTIVITY THAN THE CONTROL GROUP. [CONCLUSIONS] HATHA YOGA EXERCISE IMPROVES FLEXIBILITY, MUSCLE TONE AND STRENGTH, BALANCE, AND JOINT FUNCTION. OUR FINDINGS INDICATE THAT REGULAR AND CONTINUOUS YOGA EXERCISE EFFECTIVELY IMPROVED BODY COMPOSITION, DECREASE PLASMA MDA CONCENTRATION, AND INCREASE PLASMA SOD ACTIVITY IN FEMALE PATIENTS WITH SHOULDER PAIN. 2015 17 1328 51 HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASES FOLLOWING A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION: A NON-PHARMACOLOGICAL MODULATION. OBJECTIVES: THE OBJECTIVE OF THE STUDY WAS TO ASSESS THE EFFECT OF A BRIEF BUT COMPREHENSIVE YOGA-BASED LIFESTYLE INTERVENTION ON HIGH-DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C). METHODS: THIS PROSPECTIVE INTERVENTIONAL STUDY WAS PERFORMED AT THE INTEGRAL HEALTH CLINIC (IHC), AN OUTPATIENT FACILITY AT ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI, A TERTIARY HEALTH CARE CENTRE, CONDUCTING YOGA-BASED LIFESTYLE INTERVENTION PROGRAMMES FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. THE STUDY INCLUDED APPARENTLY HEALTHY NORMAL WEIGHT, OVERWEIGHT AND OBESE SUBJECTS WHO UNDERWENT A PRETESTED 10-DAY YOGA-BASED PROGRAMME INCLUDING ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), MEDITATION, GROUP DISCUSSIONS, LECTURES AND INDIVIDUALIZED ADVICE ON STRESS MANAGEMENT AND HEALTHY DIET. THE PRIMARY OUTCOME MEASURE WAS CHANGE IN SERUM HDL-C AT DAY 10 VERSUS DAY 0. RESULTS: 238 PARTICIPANTS (147 WOMEN, 91 MEN, 38.81+/-11.40 YEARS) WERE INCLUDED IN THE STUDY. THERE WAS A SIGNIFICANT INCREASE IN HDL-C LEVELS FROM BASELINE TO DAY 10 (42.93+/-5.00 VS 43.52+/-5.07 MG/DL, P = 0.043). NOTABLY, HDL-C WAS SIGNIFICANTLY IMPROVED IN THOSE FOR WHOM THE BASELINE HDL-C LEVELS WERE LOWER THAN THE RECOMMENDED VALUES. ALSO, THERE WAS A REDUCTION IN BLOOD PRESSURE, FASTING BLOOD GLUCOSE, AND IMPROVEMENT IN OTHER LIPID PROFILE VARIABLES. CONCLUSION: THIS YOGA-BASED LIFESTYLE INTERVENTION SIGNIFICANTLY INCREASED HDL-C LEVELS IN A SHORT DURATION OF 10 DAYS. THIS HAS ADDITIONAL CLINICAL RELEVANCE AS HDL-C IS SUGGESTED TO BE ONE OF THE STRONGEST STATISTICALLY INDEPENDENT PREDICTORS OF MAJOR CARDIOVASCULAR EVENTS. 2014 18 938 31 EFFECTS OF 1-YEAR YOGA ON CARDIOVASCULAR RISK FACTORS IN MIDDLE-AGED AND OLDER ADULTS WITH METABOLIC SYNDROME: A RANDOMIZED TRIAL. BACKGROUND: METABOLIC SYNDROME (METS) IS A CLUSTERING OF CARDIOVASCULAR RISK FACTORS, WHICH IS ASSOCIATED WITH DIABETES MELLITUS AND CARDIOVASCULAR DISEASE. LIFESTYLE INTERVENTIONS APPLIED TO PEOPLE WITH METS HAS CONSIDERABLE BENEFICIAL EFFECTS ON DISEASE PREVENTIVE OUTCOMES. THIS STUDY AIMED TO EXAMINE THE EFFECTS OF 1-YEAR OF YOGA EXERCISE ON THE CARDIOVASCULAR RISK FACTORS INCLUDING CENTRAL OBESITY, HYPERTENSION, DYSLIPIDEMIA AND HYPERGLYCEMIA IN MIDDLE-AGED AND OLDER HONG KONG CHINESE ADULTS WITH METS. METHODS: ADULTS DIAGNOSED WITH METS USING NATIONAL CHOLESTEROL EDUCATION PROGRAM CRITERIA (N = 182; MEAN +/- SD AGE = 56 +/- 9.1) WERE RANDOMLY ASSIGNED TO A 1-YEAR YOGA INTERVENTION GROUP OR CONTROL GROUP. SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, WAIST CIRCUMFERENCE, FASTING PLASMA GLUCOSE, TRIGLYCERIDES, AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL WERE EXAMINED AT BASELINE, MIDWAY, AND ON COMPLETION OF THE STUDY. PHYSICAL ACTIVITY LEVEL AND CALORIC INTAKE WERE ASSESSED AND INCLUDED IN THE COVARIATE ANALYSES. RESULTS: A REDUCTION OF THE NUMBER OF DIAGNOSTIC COMPONENTS FOR METS WAS FOUND TO BE ASSOCIATED WITH THE YOGA INTERVENTION. WAIST CIRCUMFERENCE WAS SIGNIFICANTLY IMPROVED AFTER THE 1-YEAR YOGA INTERVENTION. A TREND TOWARDS A DECREASE IN SYSTOLIC BLOOD PRESSURE WAS OBSERVED FOLLOWING YOGA INTERVENTION. CONCLUSION: THESE RESULTS SUGGEST THAT YOGA EXERCISE IMPROVES THE CARDIOVASCULAR RISK FACTORS INCLUDING CENTRAL OBESITY AND BLOOD PRESSURE IN MIDDLE-AGED AND OLDER ADULTS WITH METS. THESE FINDINGS SUPPORT THE COMPLEMENTARY BENEFICIAL ROLE OF YOGA IN MANAGING METS. 2015 19 796 36 EFFECT OF YOGA INTERVENTION ON BIOCHEMICAL, OXIDATIVE STRESS MARKERS, INFLAMMATORY MARKERS AND SLEEP QUALITY AMONG SUBJECTS WITH TYPE 2 DIABETES IN SOUTH INDIA: RESULTS FROM THE SATYAM PROJECT. AIMS: THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFECT OF YOGA INTERVENTION ON THE BIOCHEMICAL, OXIDATIVE STRESS MARKERS AND INFLAMMATORY MARKERS AND SLEEP QUALITY AMONG SUBJECTS WITH TYPE 2 DIABETES. METHODS: SUBJECTS WITH TYPE 2 DIABETES ATTENDING A TERTIARY CARE CENTRE FOR DIABETES DURING FEB 2017 TO OCT 2019 IN CHENNAI, INDIA WERE RANDOMLY ASSIGNED TO TWO DIFFERENT GROUPS. GROUP1(NON-YOGA) (N = 150) WAS ADVISED ON SIMPLE PHYSICAL EXERCISES WHEREAS GROUP2(YOGA) (N = 150) WAS TRAINED AND ADVISED TO DO YOGASANAS WITH STATIC LOOSENING EXERCISES FOR 50 MIN FOR 5 DAYS IN A WEEK. BOTH THE GROUPS WERE FOLLOWED UP FOR A PERIOD OF 3 MONTHS. ANTHROPOMETRIC, BIOCHEMICAL, OXIDATIVE STRESS MARKERS, INFLAMMATORY MARKERS AND SLEEP QUALITY WERE ASSESSED AT BASELINE AND AFTER FOLLOW UP. RESULTS: THERE WAS A SIGNIFICANT REDUCTION IN BMI, BLOOD GLUCOSE LEVELS, HBA1C, LIPID LEVELS, IL6, TNFALPHA AND TBARS IN YOGA GROUP AS COMPARED TO NON-YOGA GROUP. THERE WAS MARKED IMPROVEMENT IN THE LEVELS OF ADIPONECTIN, PTGIS AND SLEEP QUALITY AMONG SUBJECTS PRACTISING YOGASANAS. CONCLUSION: REGULAR PRACTICE OF YOGASANAS IMPROVED GLYCAEMIC CONTROL, OXIDATIVE STRESS, INFLAMMATORY RESPONSE AND SLEEP QUALITY AMONG SUBJECTS WITH TYPE 2 DIABETES. HENCE, YOGASANAS CAN BE USED AS AN ADJUVANT THERAPY FOR MANAGING TYPE 2 DIABETES. 2021 20 685 32 EFFECT OF AN INTEGRATED NATUROPATHY AND YOGA PROGRAM ON LONG-TERM GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS PATIENTS: A PROSPECTIVE COHORT STUDY. AIM: LIFESTYLE IS AN IMPORTANT RISK FACTOR FOR INCREASING THE PREVALENCE OF DIABETES IN THE INDIAN POPULATION. IN THIS STUDY, WE EVALUATE THE EFFECTS OF NATUROPATHY TREATMENT, SALT-RESTRICTED LOW-CALORIE DIETS, AND YOGA IN LONG-TERM GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. METHODS: IN THIS PROSPECTIVE, LONGITUDINAL, TWO-ARM COHORT STUDY, PATIENTS WITH TYPE 2 DIABETES MELLITUS REFERRED FROM A TERTIARY CARE CENTER UNDERGOING A 3-MONTH RESIDENTIAL NATUROPATHY TREATMENT WERE COMPARED WITH THOSE UNDERGOING ONLY CONVENTIONAL MANAGEMENT ON GLYCEMIC CONTROL. BOTH FASTING AND POSTPRANDIAL BLOOD GLUCOSE (PPBG) LEVELS WERE ASSESSED AT BASELINE, 3 MONTHS FOLLOWING INTERVENTION, AT 6 MONTHS, AND 12 MONTHS FROM THE STUDY START. DATA WERE ANALYZED USING REPEATED-MEASURES ANOVA WITH POST HOC BONFERRONI CORRECTION. RESULTS: NATUROPATHY AND YOGA INTERVENTION SIGNIFICANTLY REDUCED PPBG LEVELS (P < 0.001), GLYCATED HEMOGLOBIN LEVELS (P < 0.001), AND REDUCED REQUIREMENT FOR ANTIDIABETIC MEDICATIONS (P < 0.008) IN THE INTERVENTION GROUP COMPARED TO CONTROLS. THE EFFECTS WERE MORE PROFOUND IMMEDIATELY FOLLOWING INTERVENTION AND LASTED UP TO 6 MONTHS FROM THE START OF THE STUDY. CONCLUSION: THE RESULTS SUGGEST BENEFIT WITH AN INTENSIVE RESIDENTIAL NATUROPATHY-BASED LIFESTYLE INTERVENTION PROGRAM. RANDOMIZED CONTROLLED TRIALS ARE NEEDED TO FURTHER VALIDATE THE FINDINGS. 2020